1) J. Med. Chem., 37 (1994) N 16, S 2552-2563
Norman Mark H., Rigdon Greg C., Navas Frank (III), Cooper Barrett R.
Cyclic benzamides as mixed dopamine D[2]/serotonin 5-HT[2] receptor antagonists: potential atypical antipsychotic agents
- DOI:
http://dx.doi.org/10.1021/jm00042a008
Matsui Toshiaki, Sugiura Tsuneyuki, Nakai Hisao, Iguchi Sadahiko, Shigeoka Satoshi, Takada Hideo, Odagaki Yoshihiko, Nagao Yuhki, Ushio Yasuyuki, Ohmoto Kazuyuki, Iwamura Hiroyuki, Yamazaki Shinichi, Arai Yoshinobu, Kawamura Masanori:
Novel 5-HT[3] antagonists. Isoquinolinones and 3-aryl-2-pyridones
- DOI:
http://dx.doi.org/10.1021/jm00096a001
Yamaguchi Masahisa, Kamei Kenshi, Koga Takaki, Akima Michitaka, KurokiToshio, Ohi Nobuhiro
Novel antiasthmatic agents with dual activities of thromboxane A[2] synthetase inhibition and bronchodilation. 1. 2-[2-(1-imidazolyl)alkyl]-1(2N)-phthalazinones
- DOI:
http://dx.doi.org/10.1021/jm00077a008
Dogruer Deniz S., Kupeli Esra, Yesilada Erdem, Sahin M. Fethi
Synthesis of new 2-[1(2H)-phthalazinon-2-yl]acetamide and 3-[1(2H)-phthalazinon-2-yl]propanamide derivatives as antinociceptive and anti-inflammatory agents
- DOI:
http://dx.doi.org/10.1002/ardp.200200719